Transplantation Proceedings
Volume 39, Issue 3 , Pages 600-601 , April 2007

Report of the Experience With Enteric-Coated Sodium Mycophenolate in a De Novo Population of Kidney Transplant Recipients at High Risk for Delayed Graft Function

References 

  1. Sollinger HW U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation. 1995;60:225
  2. Meier Kriesche HU, Steffen B, Hochberg AM, et al. Long term use of mycophenolate mofetil is associated with a reduction in incidence and risk of late rejection. Am J Transplant. 2003;3:68
  3. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: etiology, incidence and management. Drug Saf. 2001;24:645
  4. Pelletier RP, Akin B, Henry ML, et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant. 2003;17:200
  5. Knoll GA, MacDonald I, Khan A, et al. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol. 2003;14:2381
  6. Hardinger KL, Brenan DC, Lowell J, et al. Long term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int. 2004;17:609
  7. Massari P, Duro Garcia V, Giron F, et al. PROMS LatAm Study Group Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients. Transplant Proc. 2005;37:916
  8. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997;63:968
  9. Shaw LM, Holt DW, Oellerich M, et al. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a round table discussion. Ther Drug Monit. 2001;23:305
  10. Gonzalez-Roncero FM, Gentil MA, Brunet M, et al. Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency. Transplant Proc. 2005;37:3749
  11. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized, clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaver renal transplantation. Transplantation. 1996;61:1029

PII: S0041-1345(06)01576-4

doi: 10.1016/j.transproceed.2006.12.029

Transplantation Proceedings
Volume 39, Issue 3 , Pages 600-601 , April 2007

Article Tools